Atrial Remodeling And Atrial Fibrillation: Mechanistic Interactions And Clinical Implications

Bandar Al Ghamdi1, Walid Hassan1

  • 1King Faisal Specialist Hospital and research centre, Riyadh, Saudi Arabia.

Insights

Atrial fibrillation (AF), a common heart rhythm disorder, is linked to stroke and mortality. Understanding atrial remodeling (AR) is key to developing effective treatments for AF.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Pathophysiology

Background:

  • Atrial fibrillation (AF) is the most prevalent clinical arrhythmia, increasing with age.
  • High-risk patients face significant thromboembolic stroke risk and mortality.
  • The precise mechanisms of AF genesis remain incompletely understood, with evolving theories beyond re-entrant circuits.

Purpose of the Study:

  • To review the mechanisms of atrial remodeling (AR).
  • To discuss structural, electrophysiologic, and neurohormonal changes in AR.
  • To explore AR's role in AF initiation and maintenance, including inflammation and therapeutic interventions.

Main Methods:

  • Review of existing animal and human studies on atrial remodeling (AR) and AF.
  • Analysis of structural, electrophysiological, and neurohormonal changes associated with AR.
  • Discussion of the role of inflammation in AR and AF.

Main Results:

  • AF triggers complex interactions leading to abnormal atrial substrates and remodeling.
  • Atrial remodeling (AR) involves structural and electrical changes that promote AF maintenance.
  • Inflammation plays a role in AR and AF initiation/maintenance.

Conclusions:

  • Understanding AR mechanisms is crucial for effective AF ablation strategies.
  • AR is central to both the development and persistence of atrial fibrillation.
  • Targeting AR may offer therapeutic avenues to prevent AF.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.4K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
522
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
716
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
547
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
777
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K